Last checked at 
(Correcting name and headquarters location of Aperion Biologics.)
Tissue Regenix Group PLC - Leeds-based medical devices for regenerative medicine - Hires David Cocke as chief financial officer and board director. Cocke founded NuPak Medical Ltd, a contract manufacturer of sterile disposable medical devices, back in 1997. NuPak was acquired by Katena Products Inc in 2017. Cocke also was CFO of San Antonio, Texas-based Aperion Biologics Inc. He starts at Tissue Regenix immediately.
Current stock price: 0.51 pence
Year-to-date change: down 5.6%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
